Top Clinical Trials companies in Israel by Dividends Paid
Israel
# |
Name |
Dividends Paid |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 0.00
|
Dec. 31, 2023 | USD 0.01 | -11.50% |
|
Israel |
|
| 2 |
USD 0.00
|
Dec. 31, 2023 | USD 0.01 | 0.04% |
|
Israel |
|
| 3 |
USD 0.00
|
Dec. 31, 2023 | USD 1.85 | 10.75% |
|
Israel |
|
| 4 |
USD 0.00
|
Dec. 31, 2023 | USD 1.90 | -4.04% |
|
Israel |
|
| 5 |
USD 0.00
|
Dec. 31, 2023 | USD 4.00 | 8.11% |
|
Israel |
|
| 6 |
USD 0.00
|
Dec. 31, 2023 | USD 1.16 | -2.88% |
|
Israel |
|
| 7 |
USD 0.00
|
Dec. 31, 2023 | USD 2.36 | -1.67% |
|
Israel |
|
| 8 |
USD 0.00
|
Dec. 31, 2023 | USD 2.82 | -2.08% |
|
Israel |
|
| 9 |
USD 0.00
|
Dec. 31, 2023 | USD 1.03 | -0.96% |
|
Israel |
|
| 10 |
USD 0.00
|
Dec. 31, 2023 | USD 0.02 | -1.36% |
|
Israel |
|
| 11 |
USD 0.00
|
Dec. 31, 2023 | USD 2.74 | -3.52% |
|
Israel |
Frequently Asked Questions
-
Which Clinical Trials company in Israel has the highest Dividends Paid ?
The Clinical Trials company in Israel with the highest Dividends Paid is BioLineRx Ltd. (Tel Aviv Stock Exchange: BLRX.TA) at USD 0.00.
-
Which Clinical Trials company in Israel has the lowest Dividends Paid ?
The Clinical Trials company in Israel with the lowest Dividends Paid is PainReform Ltd. (NasdaqCM: PRFX) at USD 0.00.
-
What are the top 10 Clinical Trials companies in Israel by Dividends Paid ?
The top 10 Clinical Trials companies in Israel by Dividends Paid are BioLineRx Ltd., Can-Fite BioPharma Ltd., Compugen Ltd., Chemomab Therapeutics Ltd., Alpha Tau Medical Ltd., Enlivex Therapeutics Ltd., Entera Bio Ltd., Galmed Pharmaceuticals Ltd., NeuroSense Therapeutics Ltd. and Purple Biotech Ltd..
-
What are the bottom 10 Clinical Trials companies in Israel by Dividends Paid ?
The bottom 10 Clinical Trials companies in Israel by Dividends Paid are PainReform Ltd., Purple Biotech Ltd., NeuroSense Therapeutics Ltd., Galmed Pharmaceuticals Ltd., Entera Bio Ltd., Enlivex Therapeutics Ltd., Alpha Tau Medical Ltd., Chemomab Therapeutics Ltd., Compugen Ltd. and Can-Fite BioPharma Ltd..